DXCM vs GEHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DXCM · DexCom$79.41 ▼ 5.98%
GEHC · GE HealthCare Technologies$82.38 ▼ 1.64%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DXCM +44.8%
- GEHC +12.3%
Head to head
| Metric | DXCM | GEHC |
|---|---|---|
| Price | $79.41 | $82.38 |
| Change today | ▼ 5.98% | ▼ 1.64% |
| Market cap | $29.62B | $37.25B |
| Return, 3 months | -9.4% | +12.9% |
| Return, year to date | +19.6% | +0.6% |
| Return, 1 year | +44.4% | +12.9% |
| P/E (TTM) | 31.3 | 17.4 |
| P/B | 11.7 | 3.2 |
| P/E percentile vs own 5y | 6th | 43rd |
| Dividend yield | – | 0.17% |
| Revenue growth (YoY, latest qtr) | +11.2% | +7.2% |
| Net profit growth (YoY) | -3.1% | +34.3% |
| Gross margin | 63.4% | 39.9% |
| Operating margin | 24.0% | 13.3% |
| Net margin | 19.4% | 10.0% |
| Return on equity | 37.7% | 19.9% |
| Analyst target vs. price | +24.9% | +2.4% |
| Analyst buy share | 93% | 62% |
| RSI (14) | 43 | 72 |
| 30-day volatility | 45.1% | 36.0% |
| Max drawdown, 1 year | -22.6% | -32.5% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GEHC is the largest of the group by market value.
- DXCM has returned the most over the past year.
- GEHC carries the lowest trailing P/E.
- DXCM is growing revenue fastest.
- DXCM keeps the most profit per dollar of sales.
- GEHC has been the calmest stock over the last 30 days.